Targeting cancer stem cell pathways for cancer therapy

L Yang, P Shi, G Zhao, J Xu, W Peng, J Zhang… - Signal transduction and …, 2020 - nature.com
Since cancer stem cells (CSCs) were first identified in leukemia in 1994, they have been
considered promising therapeutic targets for cancer therapy. These cells have self-renewal …

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

YR Li, Y Fang, Z Lyu, Y Zhu, L Yang - Journal of Translational Medicine, 2023 - Springer
Cancer stem cells (CSCs) have emerged as key contributors to tumor initiation, growth, and
metastasis. In addition, CSCs play a significant role in inducing immune evasion, thereby …

Targeting gastric cancer stem cells to enhance treatment response

X Rao, C Zhang, H Luo, J Zhang, Z Zhuang, Z Liang… - Cells, 2022 - mdpi.com
Gastric cancer (GC) was the fourth deadliest cancer in the world in 2020, and about 770,000
people died from GC that year. The death of patients with GC is mainly caused by the …

[HTML][HTML] Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance

MR Makena, A Ranjan, V Thirumala… - Biochimica et Biophysica …, 2020 - Elsevier
Unlike other normal cells, a subpopulation of cells often termed as “stem cells” are long-lived
and generate cellular progeny throughout life. Cancer stem cells (CSCs) are rare immortal …

Identification of prognostic model and biomarkers for cancer stem cell characteristics in glioblastoma by network analysis of multi-omics data and stemness indices

J Du, X Yan, S Mi, Y Li, H Ji, K Hou, S Ma… - Frontiers in Cell and …, 2020 - frontiersin.org
The progression of most human cancers mainly involves the gradual accumulation of the
loss of differentiated phenotypes and the sequential acquisition of progenitor and stem cell …

[HTML][HTML] Cancer stem cells: a major culprit of intra-tumor heterogeneity

F Naz, M Shi, S Sajid, Z Yang, C Yu - American journal of cancer …, 2021 - ncbi.nlm.nih.gov
Cancer is recognized as a preeminent factor of the world's mortality. Although various
modalities have been designed to cure this life-threatening ailment, a significant impediment …

Targeting notch to maximize chemotherapeutic benefits: Rationale, advanced strategies, and future perspectives

N Zhdanovskaya, M Firrincieli, S Lazzari, E Pace… - Cancers, 2021 - mdpi.com
Simple Summary The Notch signaling pathway regulates cell proliferation, apoptosis, stem
cell self-renewal, and differentiation in a context-dependent fashion both during embryonic …

Cancer stem cells: from an insight into the basics to recent advances and therapeutic targeting

S Bisht, M Nigam, SS Kunjwal, P Sergey… - Stem Cells …, 2022 - Wiley Online Library
Cancer is characterized by an abnormal growth of the cells in an uncontrolled manner.
These cells have the potential to invade and can eventually turn into malignancy, leading to …

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4

L McClements, S Annett, A Yakkundi, M O'Rourke… - BMC cancer, 2019 - Springer
Background Optimising breast cancer treatment remains a challenge. Resistance to therapy
is a major problem in both ER-and ER+ breast cancer. Tumour recurrence after …

Atractylenolide III attenuates angiogenesis in gastric precancerous lesions through the downregulation of delta-like ligand 4

Y Gao, J Wang, M Zhao, T Xia, Q Liu, N Chen… - Frontiers in …, 2022 - frontiersin.org
Background: Blocking and even reversing gastric precancerous lesions (GPL) is a key
measure to lower the incidence of gastric cancer. Atractylenolide III (AT-III) is a mainly active …